Rex Health invests $500K in Aerial BioPharma

Rex Health Ventures has made its first investment, funding fellow CED Member Aerial BioPharma to the tune of $500,000. The deal was announced on Thursday.

Rick Smith of WRAL Tech Wire conducted interviews with a few key players involved in the deal. Key points and takeaways from these interviews can be found using the below links:

1. Interview with Bobby Helmedag, director of Operations, Rex Health Ventures;
2. Interview with Merrette Moore, advisor to Rex Health Ventures;
3. Interview with Moise Khayrallah, CEO, Aerial BioPharma

Congratulations to both Rex Health Ventures and Aerial BioPharma!